medigraphic.com

2015, Number 2

<< Back Next >>

Revista Cubana de Angiología y Cirugía Vascular 2015; 16 (2)

Combination of the curative surgical treatment and Heberprot- P® in the neuropathic ulceration of the forefoot

García HAL, Febles SR, Acosta CL, Moliner CM

Language: Spanish
References: 39
Page: 125-138
PDF size: 146.85 Kb.


ABSTRACT

Introduction: curative surgery is performed to reach healing of a diabetic foot with injures and loss of protective sensations. The available literature did not show prospective studies that supported the results attained with this surgery when applied with Heberprot-P®.
Objectives: to analyze the results of the combination of curative surgery and Heberprot-P® to treat neuropathic ulcers of the forefront.
Methods: a case series study was conducted in the provincial service of angiology in Matanzas for three years and four months, with the inclusion of 123 lower limbs with neuropathic wounds in the forefoot, which were treated with curative surgery and adjuvant Heberprot-P® therapy.
Results: the treated wounds were classified as Wagner 2 (56.1 %) and 3 (43.9 %). The infection evaluation yielded grade 1 (52.8 %) and grade 2 (47.2 %). Time of epithelization exhibits a significant reduction in the patients treated with curative surgery and adjuvant therapy with Heberprot-P®, in comparison with those untreated cases. The behavior of relapses was similar in both cases.
Conclusions: the association of curative surgery and Heberprot-P® used in diabetic patients with neuropathic wounds of the forefoot, reduces the time of epithelization and of relapses.


REFERENCES

  1. Nather A, Chionh SB, Tay PL, Aziz Z, Teng JW, Rajeswari K, et al. Foot screening for diabetics. Ann Acad Med Singapore. 2010;39:472-5.

  2. García Herrera A, Fernández Montequín JI, Rodríguez Fernández R. El pie diabético. Madrid: Editorial Elsevier; 2004.

  3. Mc Cook J, Montalvo DJ, Ariosa CM, Fernández HP. Hacia una clasificación etiopatogénica del llamado pie diabético. Angiología. 1979;31(1):7-11.

  4. Pascale R, Vitale M, Zeppa P, Russo E, Esposito S. Diabetic foot: definitions. Infezioni in Med. 2012;20(Suppl 1):5-7.

  5. Apelqvist J. Diagnostics and treatment of the diabetic foot. Endocrine. 2012;41(3):384-97.

  6. Bakker K, Apelqvist J, Schaper NC. International Working Group on Diabetic Foot Editorial Board: Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev. 2012;28(Suppl 1):225-31.

  7. García Herrera A, Rodríguez Fernández R, Peña Ruiz VM, Rodríguez Hernández L, Acosta Cabadilla L, Febles Sanabria R, et al. El significado clínico del pie diabético en un análisis de 10 años. Rev Cubana Angiol y Cir Vasc. 2011 [citado 12 Oct 2014];12(1):356-61. Disponible en: http://bvs.sld.cu/revistas/ang/vol12_01_11/ang08111.htm

  8. Nather A, Siok Bee C, Keng Lin W, Xin-Bei Valerie C, Liang S, Tambyah PA, et al. Value of team approach combined with clinical pathway for diabetic foot problems: a clinical evaluation. Diabet Foot Ankle. 2010;1:5731-42.

  9. Valabhji J, Oliver N, Samarasinghe D, Mali T, Gibbs RG, Gedroyc WM. Conservative management of diabetic forefoot ulceration complicated by underlying osteomyelitis: the benefits of magnetic resonance imaging. Diabetic Med. 2009;26(11):1127-34.

  10. Brown ML, Tang W, Patel A, Baumhauer JF. Partial foot amputation in patients with diabetic foot ulcers. Foot Ankle Int. 2012;33:707-16.

  11. Aragón Sánchez J, Lázaro Martínez JL, Hernández Herrero C, Campillo Vilorio N, Quintana Marrero Y, García Morales E, et al. Does osteomyelitis in the feet of patients with diabetes really recur after surgical treatment? Natural history of a surgical series. Diabet Med. 2012;29:813-8.

  12. Berendt AR, Peters EJ, Bakker K, Embil JM, Eneroth M, Hinchliffe RJ, et al. Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev. 2008;24:S145-61.

  13. Aragon-Sanchez J. Seminar review: a review of the basis of surgical treatment of diabetic foot infections. Int J Low Extrem Wounds. 2011;10:33-65.

  14. Gottrup F, Apelqvist J. Present and new techniques and devices in the treatment of DFU: a critical review of evidence. Diabetes Metab Res Rev. 2012;28(suppl 1):64– 71.

  15. Kosinski MA, Lipsky BA. Current medical management of diabetic foot infections. Expert. Rev Anti Infect Ther. 2010;8:1293-305.

  16. Pendsey SP. Understanding diabetic foot. Intern J Diabetes Devel Countries. 2010;30(2):75-9.

  17. Fisher T, Scimeca C, Bharara M, Mills JL, Armstrong DG. A step-wise approach for surgical management of diabetic foot infections. J Vasc Surg. 2010;52:72-5.

  18. Berlanga J, Savigne W, Valdés C, Franco N, Alba JS, del Rio A, et al. Epidermal growth factor intra-lesional infiltrations can prevent amputation in diabetic patients with advanced foot ulcers. Int Wound J. 2006;3:232-9.

  19. Game FL, Hinchliffe RJ, Apelqvist J, Armstrong DG, Bakker K, Hartemann A, et al. A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev. 2012 Feb;28(Suppl 1):119-41. doi: 10.1002/dmrr.2246.

  20. Edmonds M. Double trouble: infection and ischemia in the diabetic foot. Int J Lower Extremity Wounds. 2009;8(2):62-3.

  21. Peters EJ, Lipsky BA, Berendt AR, Embil JM, Lavery LA, Senneville E, et al. A systematic review of the effectiveness of interventions in the management of infection in the diabetic foot. Diabetes Metab Res Rev. 2012;28 (Suppl 1):142-62. doi: 10.1002/dmrr.2247.

  22. Lebrun E, Tomic-Canic M, Kirsner RS. The role of surgical debridement in healing of diabetic foot ulcers. Wound Repair Regen. 2010;18:433–8.

  23. Smith J. Desbridamiento de las úlceras del pie diabético (Revisión Cochrane traducida). La Biblioteca Cochrane Plus. 2008 [citado 12 Ene 2014]. Disponible en: http://www.update-software.com

  24. Saap LJ, Falanga V. Debridement performance index and its correlation with complete closure of diabetic foot ulcers. Wound Repair Regen. 2002;10:354–9.

  25. Sibbald RG, Goodman L, Woo KY, Krasner DL, Smart H, Tariq G, et al. Special considerations in wound bed preparation 2011: an update©. Adv Skin Wound Care. 2011;24(9):415-36;437-8. doi: 10.1097/01.ASW.0000405216.27050.97

  26. Gordon KA, Lebrun EA, Tomic-Canic M, Kirsner RS. The role of surgical debridement in healing of diabetic foot ulcers. Skinmed. 2012;10(1):24-6.

  27. Wukich DK. Current concepts review: diabetic foot ulcers. Foot Ankle Int. 2010;31:460-7.

  28. Schepers T, Berendsen HA, Oei IH, Koning J. Functional outcome and patient satisfaction after flexor tenotomy for plantar ulcers of the toes. J Foot Ankle Surg. 2010:49:119–22.

  29. Kearney TP, Hunt NA, Lavery LA. Safety and effectiveness of flexor tenotomies to heal toe ulcers in persons with diabetes. Diabetes Res Clin Pract. 2010;89:224–6.

  30. La Fontaine J, Brown D, Adams M, VanPelt M. New and recurrent ulcerations after percutaneous Achilles tendon lengthening in trans-metatarsal amputation. J Foot Ankle Surg. 2008;47:225-9.

  31. Frykberg RG, Bevilacqua NJ, Habershaw G. Surgical off-loading of the diabetic foot. J Vasc Surg. 2010;52:44-58.

  32. Salamon ML, Pinney SJ, Van Bergeyk A, Hazelwood S. Surgical anatomy and accuracy of percutaneous Achilles tendon lengthening. Foot Ankle Int. 2006;27:411-3.

  33. Hoefnagels EM, Waites MD, Belkoff SM, Swierstra BA. Percutaneous achilles tendon lengthening: a cadaver-based study of failure of the triple hemisection technique. Acta Orthop. 2007;78:808-12.

  34. Roukis TS, Schade VL. Percutaneous flexor tenotomy for treatment of neuropathic toe ulceration secondary to toe contracture in persons with diabetes: A systematic review. J Foot Ankle Surg. 2009;48:684–9.

  35. Laborde JM. Neuropathic toe ulcers treated with toe flexor tenotomies. Foot Ankle Int. 2007;28:1161-3.

  36. Fernández Montequín JI, Infante Cristiá E, Valenzuela Silva C, Franco Pérez N, Savigne Gutiérrez W, Artaza Sanz H, et al. Intralesional injections of Heberprot-P® (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation. Int Wound J. 2007;4:333-43.

  37. Fernández Montequín JI, Betancourt BY, Leyva Gonzalez G, López Mola E, Galán Naranjo K, Ramírez Navas M, et al. Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in advanced diabetic foot ulcer: Treatment up to complete wound closure. Int Wound J. 2009;6:67-72.

  38. Fan WPL, Rashid M, Enoch S. Current advances in modern wound healing. Wounds UK. 2010;6(3):22-36.

  39. Lo Pardo D, Pezzuti G, Selleri C, Pepe S, Esposito S. Adjuvant treatment of diabetic foot. Infezioni Med. 2012;20 (Suppl 1):35-41.




2020     |     www.medigraphic.com